Breast cancer: Chemotherapy in the treatment of advanced disease
Authors:
- G. CatimelGCG. Catimel
- 31 December 1993
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 29 (4) , 598-604
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI: Journal of the National Cancer Institute, 1991
- Randomized Trial of Doxorubicin, Bisantrene, and Miltoxantrone in Advanced Breast Cancer: A Southwest Oncology Group StudyJNCI: Journal of the National Cancer Institute, 1991
- Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancerThe Lancet, 1990
- Highly efficient, practical approach to natural taxolJournal of the American Chemical Society, 1988
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987
- A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer A Cancer and Leukemia Group B studyAmerican Journal of Clinical Oncology, 1984
- The interpretation of trials: Combined hormonal therapy and chemotherapy in disseminated breast cancerBreast Cancer Research and Treatment, 1981
- An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patientsCancer, 1980
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976
- Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancerCancer, 1975